INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2020

Revascularization provided no long-term quality of life or walking benefit over exercise therapy and medical therapy alone in intermittent claudication.

The IRONIC trial randomized 158 patients with mild-to-severe intermittent claudication to revascularization plus medical therapy and structured exercise, or medical therapy and structured exercise alone. At 5 years, no significant intergroup differences were observed for SF-36 scores, except for the role emotional domain which favored the nonrevascularization group (P=0.007). There were also no differences in VascuQoL scores or treadmill walking distances, while revascularization incurred nearly double the cost per patient ($13,098 vs $6,965, P=0.02).

Study type
Randomized controlled trial
Who was studied
158 patients with mild-to-severe intermittent claudication
What was measured
Health-related quality of life (SF-36), VascuQoL, treadmill walking distances, and cost-effectiveness at 5 years

THE PAPER

Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial.

Djerf H, Millinger J, Falkenberg M, Jivegård L, Svensson M, Nordanstig J. Circ Cardiovasc Interv, 2020.

PubMed 31937137 ↗DOI 10.1161/circinterventions.119.008450 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.